BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 10980975)

  • 1. Mesalamine for prophylaxis of small bowel Crohn's disease recurrence.
    Bauer WM; Brzezinski A; Lashner BA
    Curr Gastroenterol Rep; 1999 Oct; 1(5):377-83. PubMed ID: 10980975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of postoperative recurrence of Crohn's disease.
    van Loo ES; Dijkstra G; Ploeg RJ; Nieuwenhuijs VB
    J Crohns Colitis; 2012 Jul; 6(6):637-46. PubMed ID: 22398096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.
    Lochs H; Mayer M; Fleig WE; Mortensen PB; Bauer P; Genser D; Petritsch W; Raithel M; Hoffmann R; Gross V; Plauth M; Staun M; Nesje LB
    Gastroenterology; 2000 Feb; 118(2):264-73. PubMed ID: 10648454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: a meta-analysis of controlled trials.
    Carla-Moreau A; Paul S; Roblin X; Genin C; Peyrin-Biroulet L
    Dig Liver Dis; 2015 Mar; 47(3):191-6. PubMed ID: 25488057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: prevention of postsurgical relapse and recurrence in Crohn's disease.
    Cottone M; Orlando A; Viscido A; Calabrese E; Cammà C; Casà A
    Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():38-42. PubMed ID: 12786611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's disease.
    Doherty GA; Miksad RA; Cheifetz AS; Moss AC
    Inflamm Bowel Dis; 2012 Sep; 18(9):1608-16. PubMed ID: 21905173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease.
    Bonapace CR; Mays DA
    Ann Pharmacother; 1997; 31(7-8):907-13. PubMed ID: 9220055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesalamine and relapse prevention in Crohn's disease.
    Cottone M; Cammà C
    Gastroenterology; 2000 Aug; 119(2):597. PubMed ID: 10960274
    [No Abstract]   [Full Text] [Related]  

  • 9. The case against using 5-aminosalicyclates in Crohn's disease: con.
    Stange EF
    Inflamm Bowel Dis; 2005 Jun; 11(6):613-5. PubMed ID: 15905711
    [No Abstract]   [Full Text] [Related]  

  • 10. Debate: should mesalamine be used in Crohn's disease?: comments and conclusions.
    Kamm MA
    Inflamm Bowel Dis; 2005 Jun; 11(6):616-7. PubMed ID: 15905712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Little benefit from mesalazine taken prophylactically after surgery for Crohn's disease.
    Rutgeerts P
    Gut; 2001 Apr; 48(4):452-3. PubMed ID: 11247886
    [No Abstract]   [Full Text] [Related]  

  • 12. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
    Savarino E; Bodini G; Dulbecco P; Assandri L; Bruzzone L; Mazza F; Frigo AC; Fazio V; Marabotto E; Savarino V
    Am J Gastroenterol; 2013 Nov; 108(11):1731-42. PubMed ID: 24019080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesalamine derivatives in the treatment of Crohn's disease.
    Harrell LE; Hanauer SB
    Gastroenterol Clin North Am; 2004 Jun; 33(2):303-17, ix-x. PubMed ID: 15177540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical therapy to reduce postoperative Crohn's disease recurrence.
    Achkar JP; Hanauer SB
    Am J Gastroenterol; 2000 May; 95(5):1139-46. PubMed ID: 10811318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Azathioprine and mesalazine in the prevention of postsurgical recurrence of Crohn's disease: a retrospective study].
    Domènech E; Scala L; Bernal I; García-Planella E; Casalots A; Piñol M; Esteve-Comas M; Cabré E; Boix J; Gassull MA
    Gastroenterol Hepatol; 2004 Dec; 27(10):563-7. PubMed ID: 15574279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.
    Hanauer SB; Korelitz BI; Rutgeerts P; Peppercorn MA; Thisted RA; Cohen RD; Present DH
    Gastroenterology; 2004 Sep; 127(3):723-9. PubMed ID: 15362027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for prevention of post-operative recurrence of Crohn's disease.
    Doherty G; Bennett G; Patil S; Cheifetz A; Moss AC
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006873. PubMed ID: 19821389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obstructing Crohn's disease of the duodenum: is surgery always mandatory?
    Karaoglu AO; Yukselen V
    Int J Clin Pract; 2004 Feb; 58(2):221-3. PubMed ID: 15055874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The case for using 5-aminosalicyclates in Crohn's disease: pro.
    Hanauer SB
    Inflamm Bowel Dis; 2005 Jun; 11(6):609-12. PubMed ID: 15905710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminosalicylates for induction of remission or response in Crohn's disease.
    Lim WC; Hanauer S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008870. PubMed ID: 21154400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.